Post-treatment care program for breast and prostate cancer survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot implements an active screening program using a comprehensive questionnaire and quality-of-life measures to identify physical, psychological, social, occupational, and financial effects after completion of curative cancer therapy. The tool is designed to align with ESMO survivorship recommendations and to highlight opportunities for lifestyle interventions and early detection of recurrence. Eligible participants are adults with histologically confirmed invasive breast or prostate cancer who have completed the acute phase of curative treatment and are available for follow-up within 12 months. The program is being tested at the Masaryk Memorial Cancer Institute to inform follow-up planning and timely referrals.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* The patient understands the information provided and agrees to participate in the study.
* Age 18 years or older.
* Histologically confirmed invasive breast cancer or invasive prostate cancer.
* Completion of the acute phase of curative oncological therapy:

  * for breast cancer: curative surgery performed + completed neoadjuvant/adjuvant chemotherapy and completed adjuvant radiotherapy, if indicated
  * for prostate cancer: completed radiotherapy with curative intent or radical prostatectomy performed (open, laparoscopic, robotic) or completed adjuvant radiotherapy after prostatectomy
* The patient is available for follow-up within 12 months of enrollment in the study.

Exclusion Criteria:

* Active ongoing oncological therapy (except for (i) adjuvant hormone therapy, (ii) adjuvant targeted therapy (anti-HER2 therapy, CDK4/6i, PARPi, T-DM1), (iii) adjuvant immunotherapy)
* Neoadjuvant/adjuvant therapy did not include chemotherapy (breast cancer).
* Recurrence of cancer
* Metastatic disease
* History of other primary malignancy (except for non-melanoma skin cancer)

Where it's running

• Masaryk Memorial Cancer Institute
  Brno, Czechia Recruiting

Study contacts

• Study coordinator: Lenka Pavčíková, MUDr.
• Email: lenka.pavcikova@mou.cz
• Phone: +420 543 136 136

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Radiation therapy options for high-risk prostate cancer

  This trial tests different ways of giving radiation therapy to see which balance best controls the cancer with the fewest side effects in men with high-risk, non-metastatic prostate cancer.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07751159

• Understanding needs of prostate cancer patients and caregivers during and after radiotherapy

  We ask men receiving curative radiotherapy for prostate cancer and their caregivers about their experiences, needs, and what they'd want from prehabilitation before or during treatment.

  Recruiting Charite University, Berlin, Germany · Berlin · NCT07156903

• Breast biomechanics and bra support after surgery and radiotherapy.

  We will test whether 3D scans and sensors can measure how surgery with or without radiotherapy changes breast movement and bra support needs in women treated for unilateral breast cancer.

  Recruiting Portsmouth Hospitals NHS Trust · Portsmouth · NCT07135960

• DNA vaccine plus nivolumab and targeted radiation for recurrent oligometastatic prostate cancer

  This study will try a DNA vaccine called pTVG-HP together with the checkpoint blocker nivolumab and targeted radiation to see if they can eliminate metastatic tumors in men with non-castrate, recurrent oligometastatic prostate cancer.

  Recruiting Phase 1 University of Wisconsin, Madison · Madison, Wisconsin · NCT07090148

• One-stage prepectoral implant versus two-stage expander-to-implant breast reconstruction after mastectomy and radiotherapy

  This compares immediate one-stage prepectoral implant reconstruction with two-stage expander-to-implant reconstruction in women who will have radiotherapy after mastectomy to see if one approach gives better quality of life and fewer complications.

  Recruiting Henan Cancer Hospital · Henan, Henan · NCT07037576

• Laparoscopic nipple- and areola-sparing mastectomy with immediate implant, patch, and fat grafting reconstruction

  This will test whether laparoscopic nipple- and areola-sparing mastectomy with an immediate pectoral-muscle implant plus patch and same-time autologous fat grafting is safe and effective for women with early unilateral breast cancer (cT1-2N0M0).

  Recruiting Henan Cancer Hospital · Zhengzhou, Henan · NCT07037537

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.